Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Pfizer completes Embrex acquisition

Pfizer Animal Health has completed its acquisition of US-based Embrex, the manufacturer of the Inovoject poultry vaccination system. The deal, announced in December 2006 (Animal Pharm No 602, p 1), was just approved by Embrex shareholders for a price of around $155m. Embrex will keep its headquarters in the Raleigh-Durham, North Carolina, area. The company, which has been delisted from the NASDAQ stock exchange, is now a fully owned subsidiary of New York-based Pfizer, which re-enters the poultry business for the first time since 2000, when it sold its feed-additive business to Phibro (Animal Pharm No 454, p 17).


What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts